• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去铁胺增强三阴性 MDA-MB-231 乳腺癌细胞中线粒体铁积累并通过 ROS 依赖机制促进细胞迁移。

Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.

机构信息

School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200000, China.

School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200000, China.

出版信息

Int J Mol Sci. 2019 Oct 8;20(19):4952. doi: 10.3390/ijms20194952.

DOI:10.3390/ijms20194952
PMID:31597263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6801410/
Abstract

In our previous study, Deferoxamine (DFO) increased the iron concentration by upregulating the expression levels of TfR1 and DMT1 and exacerbated the migration of triple-negative breast cancer cells. However, the mechanisms of iron distribution and utilization in triple-negative breast cancer cells with a DFO-induced iron deficiency are still unclear. In this study, triple-negative MDA-MB-231 and estrogen receptor (ER)-positive MCF-7 breast cancer cells were used to investigate the mechanisms of iron distribution and utilization with a DFO-induced iron deficiency. We found that the mitochondrial iron concentration was elevated in MDA-MB-231 cells, while it was decreased in MCF-7 cells after DFO treatment. The cellular and mitochondrial reactive oxygen species (ROS) levels increased in both breast cancer cell types under DFO-induced iron-deficient conditions. However, the increased ROS levels had different effects on the different breast cancer cell types: Cell viability was inhibited and apoptosis was enhanced in MCF-7 cells, but cell viability was maintained and cell migration was promoted in MDA-MB-231 cells through the ROS/NF-κB and ROS/TGF-β signaling pathways. Collectively, this study suggests that under DFO-induced iron-deficient conditions, the increased mitochondrial iron levels in triple-negative MDA-MB-231 breast cancer cells would generate large amounts of ROS to activate the NF-κB and TGF-β signaling pathways to promote cell migration.

摘要

在我们之前的研究中,去铁胺 (DFO) 通过上调 TfR1 和 DMT1 的表达水平来增加铁浓度,并加剧三阴性乳腺癌细胞的迁移。然而,DFO 诱导铁缺乏时三阴性乳腺癌细胞中铁的分布和利用机制仍不清楚。在这项研究中,我们使用三阴性 MDA-MB-231 和雌激素受体 (ER) 阳性 MCF-7 乳腺癌细胞来研究 DFO 诱导铁缺乏时铁的分布和利用机制。我们发现,DFO 处理后 MDA-MB-231 细胞中线粒体铁浓度升高,而 MCF-7 细胞中铁浓度降低。在 DFO 诱导的铁缺乏条件下,两种乳腺癌细胞类型中的细胞和线粒体活性氧 (ROS) 水平均升高。然而,增加的 ROS 水平对不同的乳腺癌细胞类型有不同的影响:在 MCF-7 细胞中,细胞活力受到抑制,细胞凋亡增强,但通过 ROS/NF-κB 和 ROS/TGF-β 信号通路,MDA-MB-231 细胞中的细胞活力得以维持,细胞迁移得到促进。综上所述,本研究表明,在 DFO 诱导的铁缺乏条件下,三阴性 MDA-MB-231 乳腺癌细胞中线粒体铁水平的升高会产生大量的 ROS,激活 NF-κB 和 TGF-β 信号通路,促进细胞迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/484e90ddc4ba/ijms-20-04952-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/c3f4b3864984/ijms-20-04952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/5e2a91268896/ijms-20-04952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/ed5a241f5ef0/ijms-20-04952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/91c238f5c3a6/ijms-20-04952-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/76a980dc5e00/ijms-20-04952-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/484e90ddc4ba/ijms-20-04952-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/c3f4b3864984/ijms-20-04952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/5e2a91268896/ijms-20-04952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/ed5a241f5ef0/ijms-20-04952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/91c238f5c3a6/ijms-20-04952-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/76a980dc5e00/ijms-20-04952-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b421/6801410/484e90ddc4ba/ijms-20-04952-g006.jpg

相似文献

1
Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism.去铁胺增强三阴性 MDA-MB-231 乳腺癌细胞中线粒体铁积累并通过 ROS 依赖机制促进细胞迁移。
Int J Mol Sci. 2019 Oct 8;20(19):4952. doi: 10.3390/ijms20194952.
2
Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling.去铁胺诱导高侵袭性乳腺癌细胞内铁水平升高,通过增强肿瘤坏死因子-α依赖性核因子-κB信号传导和转化生长因子-β信号传导,导致细胞迁移增加。
J Inorg Biochem. 2016 Jul;160:40-8. doi: 10.1016/j.jinorgbio.2016.04.014. Epub 2016 Apr 14.
3
Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway.去铁胺诱导的转铁蛋白受体1(TfR1)和二价金属离子转运体1(DMT1)高表达通过激活白细胞介素-6(IL-6)/磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(AKT)通路增强三阴性乳腺癌细胞的铁摄取。
Onco Targets Ther. 2019 May 31;12:4359-4377. doi: 10.2147/OTT.S193507. eCollection 2019.
4
Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.去铁胺通过增加活性氧依赖性缺氧诱导因子-1α的积累促进MDA-MB-231细胞迁移和侵袭。
Cell Physiol Biochem. 2014;33(4):1036-46. doi: 10.1159/000358674. Epub 2014 Apr 4.
5
Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.血红素结合转铁蛋白:三阴性乳腺癌中铁死亡与放疗的联系。
Theranostics. 2021 Jan 1;11(7):3167-3182. doi: 10.7150/thno.52028. eCollection 2021.
6
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.去铁胺通过 ERK1/2 介导的线粒体功能障碍抑制食管鳞癌细胞生长。
Cancer Lett. 2018 Sep 28;432:132-143. doi: 10.1016/j.canlet.2018.06.012. Epub 2018 Jun 12.
7
Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.淫羊藿素通过抑制 SIRT6/NF-κB 触发氧化还原介导的细胞凋亡并增强三阴性乳腺癌的抗肿瘤免疫。
Cancer Sci. 2020 Nov;111(11):4242-4256. doi: 10.1111/cas.14648. Epub 2020 Oct 7.
8
Sophoraflavanone G from Sophora flavescens induces apoptosis in triple-negative breast cancer cells.槐黄酮 G 诱导三阴性乳腺癌细胞凋亡。
Phytomedicine. 2019 Aug;61:152852. doi: 10.1016/j.phymed.2019.152852. Epub 2019 Jan 29.
9
Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells.甘草次酸通过激活 NADPH 氧化酶和诱导型一氧化氮合酶,以及耗尽三阴性乳腺癌细胞中的谷胱甘肽,诱导氧化/硝化应激并引发铁死亡。
Free Radic Biol Med. 2021 Sep;173:41-51. doi: 10.1016/j.freeradbiomed.2021.07.019. Epub 2021 Jul 14.
10
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.在对乳腺癌细胞进行西拉米辛和拉帕替尼治疗后会诱导铁死亡。
Cell Death Dis. 2016 Jul 21;7(7):e2307. doi: 10.1038/cddis.2016.208.

引用本文的文献

1
The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential.铁螯合疗法在结直肠癌中的作用:关于其机制和治疗潜力的系统评价
Cancer Med. 2025 Jul;14(13):e71019. doi: 10.1002/cam4.71019.
2
Tumoroid-On-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening.盘中类肿瘤(ToP):生成生理相关癌症模型及进行治疗筛选
Adv Healthc Mater. 2025 Jan;14(1):e2402060. doi: 10.1002/adhm.202402060. Epub 2024 Nov 13.
3
Iron Metabolism in Aminolevulinic Acid-Photodynamic Therapy with Iron Chelators from the Thiosemicarbazone Group.

本文引用的文献

1
Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway.去铁胺诱导的转铁蛋白受体1(TfR1)和二价金属离子转运体1(DMT1)高表达通过激活白细胞介素-6(IL-6)/磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(AKT)通路增强三阴性乳腺癌细胞的铁摄取。
Onco Targets Ther. 2019 May 31;12:4359-4377. doi: 10.2147/OTT.S193507. eCollection 2019.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
含硫代氨基甲酰基的铁螯合剂在氨基酮戊酸光动力疗法中的铁代谢作用。
Int J Mol Sci. 2024 Sep 28;25(19):10468. doi: 10.3390/ijms251910468.
4
Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness.不同的铁调节状态导致乳腺癌侵袭性的异质性。
iScience. 2024 Aug 3;27(9):110661. doi: 10.1016/j.isci.2024.110661. eCollection 2024 Sep 20.
5
Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation.探索转移耐药性癌症中细胞复苏与线粒体活性氧介导的铁死亡之间的关系:呼吁开展研究。
Front Immunol. 2024 Jul 2;15:1428920. doi: 10.3389/fimmu.2024.1428920. eCollection 2024.
6
Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses.通过基因和蛋白质表达分析比较年轻与老年雌激素受体阳性乳腺癌的生物学特性。
Biomedicines. 2023 Jan 12;11(1):200. doi: 10.3390/biomedicines11010200.
7
SLC11A2: a promising biomarker and therapeutic target in ovarian cancer.SLC11A2:卵巢癌有前景的生物标志物和治疗靶点。
Sci Rep. 2023 Jan 20;13(1):1132. doi: 10.1038/s41598-022-26789-5.
8
Hypoxia-induced ROS aggravate tumor progression through HIF-1α-SERPINE1 signaling in glioblastoma.缺氧诱导的活性氧通过 HIF-1α-SERPINE1 信号加重胶质母细胞瘤的肿瘤进展。
J Zhejiang Univ Sci B. 2023 Jan 15;24(1):32-49. doi: 10.1631/jzus.B2200269.
9
Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery.用于皮内给药的载去铁胺纳米混悬液的溶蚀性微针
Pharmaceutics. 2022 Dec 15;14(12):2817. doi: 10.3390/pharmaceutics14122817.
10
Protective Effects of Several Common Amino Acids, Vitamins, Organic Acids, Flavonoids and Phenolic Acids against Hepatocyte Damage Caused by Alcohol.几种常见氨基酸、维生素、有机酸、黄酮类化合物和酚酸对酒精所致肝细胞损伤的保护作用
Foods. 2022 Sep 28;11(19):3014. doi: 10.3390/foods11193014.
Iron and Cancer.
铁与癌症。
Annu Rev Nutr. 2018 Aug 21;38:97-125. doi: 10.1146/annurev-nutr-082117-051732.
4
The significance, trafficking and determination of labile iron in cytosol, mitochondria and lysosomes.细胞质、线粒体和溶酶体中不稳定铁的意义、运输和测定。
Metallomics. 2018 Jul 18;10(7):899-916. doi: 10.1039/c8mt00048d.
5
Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies.教授活性氧及其与癌症生物学相关性的基础知识:线粒体活性氧的检测、氧化还原信号和靶向治疗。
Redox Biol. 2018 May;15:347-362. doi: 10.1016/j.redox.2017.12.012. Epub 2017 Dec 26.
6
Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy.肿瘤细胞上皮-间充质转化中的氧化还原调控:分子基础与治疗策略。
Signal Transduct Target Ther. 2017 Aug 18;2:17036. doi: 10.1038/sigtrans.2017.36. eCollection 2017.
7
Deferoxamine-Induced Migration and Odontoblast Differentiation via ROS-Dependent Autophagy in Dental Pulp Stem Cells.去铁胺通过活性氧依赖的自噬诱导牙髓干细胞迁移和成牙本质细胞分化。
Cell Physiol Biochem. 2017;43(6):2535-2547. doi: 10.1159/000484506. Epub 2017 Nov 1.
8
Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine.线粒体生物标志物可预测胃癌的肿瘤进展和总体生存率不佳:个性化医疗的伴随诊断。
Oncotarget. 2017 Aug 5;8(40):67117-67128. doi: 10.18632/oncotarget.19962. eCollection 2017 Sep 15.
9
Breast cancer statistics, 2017, racial disparity in mortality by state.乳腺癌统计数据,2017 年,按州划分的死亡率种族差异。
CA Cancer J Clin. 2017 Nov;67(6):439-448. doi: 10.3322/caac.21412. Epub 2017 Oct 3.
10
Iron addiction: a novel therapeutic target in ovarian cancer.铁成瘾:卵巢癌的一个新的治疗靶点。
Oncogene. 2017 Jul 20;36(29):4089-4099. doi: 10.1038/onc.2017.11. Epub 2017 Mar 20.